Zdrowie i gospodarka · 31/10/2000

FDA Proposes Withdrawal of Enrofloxacin Approval for Poultry Use

The US Food and Drug Administration (FDA) is seeking to revoke the approval of a new animal drug application for the use of enrofloxacin in poultry, citing concerns over the development of fluoroquinolone-resistant Campylobacter in poultry, which can be transferred to humans and cause serious health issues.